Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local tolerability of pedimitex solution 0.5% (permethrin) in head lice infestation
2007-006776-11Phase 2Completed
- Sponsor
- Gepepharm
- Start
- Dec 2007
- Modality
- Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of permethrin in pediculosis capitis, sponsored by Gepepharm. Primary endpoints: Local tolerability (subjective symptoms, descriptive evaluation) and Global tolerability. Started Dec 2007; status: completed.
02
Drugs
permethrin
03
Conditions
pediculosis capitis
Beyond the preview
Go deeper on 2007-006776-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-006776-11.